亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

深圳石金谷科技有限公司  

化學合成原料藥、醫藥中間體、化工原料、香精香料、食品輔料、植物提取物

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:劉艷平
  • 電話:0755-61930350
  • 郵件:sz09@yccreate.com
  • 傳真:0755-84556470
  • QQ:2355880511
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 廠家供應CAS號:204255-11-8磷酸奧司他韋
廠家供應CAS號:204255-11-8磷酸奧司他韋
單價 面議對比
詢價 暫無
發貨 廣東深圳市付款后3天內
品牌 南箭
型號 204255-11-8
規格 醫藥級
過期 長期有效
更新 2013-08-13 11:00
 
詳細信息
磷酸奧司他韋

中文別名:(3R,4R,5S)-4-乙酰胺基-5-氨基-3-(1-乙基丙氧基)-1-環己烯-1-羧酸乙酯磷酸鹽;磷酸奧司他韋;磷酸奧斯他韋;達菲/磷酸奧司他韋
CAS號:204255-11-8
分子量:410.4
分子式:C16H31N2O8P
磷酸奧司他韋 
中文別名: (3R,4R,5S)-4-乙酰胺基-5-氨基-3-(1-乙基丙氧基)-1-環己烯-1-羧酸乙酯磷酸鹽 
英文名稱: Oseltamivir phosphate 
英文別名: Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate phosphate 
CAS號: 204255-11-8 
分子式: C16H28N2O4.H3PO4 
分子量: 410.40 
磷酸奧司他韋

中文別名:(3R,4R,5S)-4-乙酰胺基-5-氨基-3-(1-乙基丙氧基)-1-環己烯-1-羧酸乙酯磷酸鹽;磷酸奧司他韋;磷酸奧斯他韋;達菲/磷酸奧司他韋
CAS號:204255-11-8
分子量:410.4
分子式:C16H31N2O8P
磷酸奧司他韋 
中文別名: (3R,4R,5S)-4-乙酰胺基-5-氨基-3-(1-乙基丙氧基)-1-環己烯-1-羧酸乙酯磷酸鹽 
英文名稱: Oseltamivir phosphate 
英文別名: Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate phosphate 
CAS號: 204255-11-8 
分子式: C16H28N2O4.H3PO4 
分子量: 410.40 
©2025 深圳石金谷科技有限公司 版權所有   技術支持:化工網   訪問量:28531  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |